详细信息
免疫原Recombinant Full Length Protein corresponding to Human IFNG. P01579
宿主/亚型Rabbit / IgG
抗体类型Polyclonal
产品形式Lyophilized
纯化方式Affinity purification Protein A
储存缓冲液pH: 7.2 Constituents: PBS
储存条件运输条件: Blue Ice
推荐的短期储存时间: 1-2 weeks
推荐的短期储存条件: +4°C
推荐的长期储存条件: -20°C
无载体蛋白No
背景信息
This product is no longer batch tested in IHC, for an IHC validated antibody please see ab231036.
文献引用 (85)
Hyodeoxycholic acid attenuates atherosclerosis by antagonizing FXR and modulating the PD-1/mTORC1 signaling axis.
脱氧胆酸通过拮抗 FXR 和调节 PD-1/mTORC1 信号轴来减轻动脉粥样硬化。
Melanocortin 1 receptor alleviates collagen-induced arthritis by upregulating T helper 1/T helper 17 cells and downregulating regulatory T cells
黑皮质素1受体通过上调T辅助细胞1/T辅助细胞17和下调调节性T细胞来缓解胶原蛋白诱导的关节炎。
Evaluation of Apoptosis and Cytotoxicity Induction Using a Recombinant Newcastle Disease Virus Expressing Human IFN-γ in Human Prostate Cancer Cells In Vitro
体外利用表达人IFN-γ的重组新城疫病毒评估人前列腺癌细胞的凋亡和细胞毒性诱导情况
Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection
与大流行相关的冻疮中留有SARS-CoV-2感染失败的痕迹
STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model
STAT3 诱饵寡脱氧核苷酸抑制肝癌细胞中的肝脏炎症和纤维化以及 DDC 诱导的肝损伤小鼠模型
Evaluation of the Local and Peripheral Immune Responses in Patients with Cystic Echinococcosis
囊型包虫病患者局部及外周免疫反应的评估
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease
在帕金森病细胞疗法中，自体Treg细胞与原体Treg细胞共同移植
Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis
通过IFNγ-cGAS-STING轴协调神经元和非神经元固有免疫反应，从而驱动轴突再生。
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy
鞘磷脂衍生的纳米囊泡用于递送IDO1抑制剂epacadostat，可增强转移性及术后黑色素瘤的免疫治疗。
STAT3/NF‑κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑κB signaling pathway in a mouse model of atherosclerosis
STAT3/NF-κB 诱饵寡脱氧核苷酸通过调节小鼠动脉粥样硬化模型中的 STAT/NF-κB 信号通路来抑制动脉粥样硬化
- 1
- 2
- 3
- 4
- 5
- 6
- 9